Medtronic wins FDA approval for stent graft to treat abdominal aneurysms
The FDA approval of the Endurant system adds yet another stent to the list of Medtronic's cadriovascular products. The company is relying on new innovative medical devices to continue to grow revenue. Medtronic estimates 1.2 million Americans suffer from abdominal aortic aneurysms, which will be treated by Endurant.